{
 "drug": "Decitabine Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "02/20/2026",
 "dayN": 186,
 "cat": "Oncology",
 "companies": [
  "Ingenus Pharmaceuticals LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "02/20/2026",
   "update_type": "New",
   "initial_posting_date": "02/20/2026",
   "package_ndc": "50742-430-01",
   "generic_name": "Decitabine Injection",
   "contact_info": "866-321-5031",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "02/20/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Decitabine, Injection, 50 mg (NDC 50742-430-01)",
   "company_name": "Ingenus Pharmaceuticals LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/20/2026",
   "update_type": "New",
   "initial_posting_date": "02/20/2026",
   "package_ndc": "68001-573-41",
   "generic_name": "Decitabine Injection",
   "contact_info": "866-321-5031",
   "related_info": "Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA210984"
    ],
    "brand_name": [
     "DECITABINE"
    ],
    "generic_name": [
     "DECITABINE"
    ],
    "manufacturer_name": [
     "BluePoint Laboratories"
    ],
    "product_ndc": [
     "68001-573"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DECITABINE"
    ],
    "rxcui": [
     "636631"
    ],
    "spl_id": [
     "fc96fe77-06cc-dc04-e053-6394a90a99da"
    ],
    "spl_set_id": [
     "6c6ab831-6234-4803-8a01-5c51ec3b0716"
    ],
    "package_ndc": [
     "68001-573-41"
    ],
    "nui": [
     "N0000000233",
     "N0000175595"
    ],
    "pharm_class_moa": [
     "Nucleic Acid Synthesis Inhibitors [MoA]"
    ],
    "pharm_class_epc": [
     "Nucleoside Metabolic Inhibitor [EPC]"
    ],
    "unii": [
     "776B62CQ27"
    ]
   },
   "update_date": "02/20/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Decitabine, Injection, 50 mg (NDC 68001-573-41)",
   "company_name": "Ingenus Pharmaceuticals LLC",
   "status": "To Be Discontinued"
  }
 ]
}